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ABSTRACT
The rollout of antiretroviral therapy globally has increased life expectancy across Southern Africa, where 20.6 million people now live with
human immunodeficiency virus (HIV). We aimed to determine the prevalence of age-related osteoporosis and sarcopenia, and investigate
theassociationbetweenHIV,bonemineraldensity (BMD),muscle strengthand leanmass, andgait speed.Across-sectional community-based
study of individuals aged 20–80 years in rural South Africa collected demographic and clinical data, including HIV status, grip strength, gait
speed, body composition, and BMD. Sarcopenia was defined by the EuropeanWorking Group on Sarcopenia in Older People 2 (EWGSOP2)
guidelines, andosteoporosis asBMDT-score≤2.5 (if age≥50 years). Themean standarddeviation (SD)ageof805blackSouthAfricanpar-
ticipantswas44.6 14.8 years, 547 (68.2%)were female; 34 (13.2%)weremen, and129 (23.6%)womenhadHIV,with88%overall takinganti-
retroviral therapy.AfemoralneckT-score≤2.5, seeninfourof95(4.2%)menand39of201(19.4%)womenage≥50 years,wasmorecommon
inwomenwiththanwithoutHIV(13/35[37.1%]versus26/166[15.7%];p=0.003).Althoughnoparticipanthadconfirmedsarcopenia,probable
sarcopenia affectedmoremen thanwomen (30/258 [11.6%] versus 24/547 [4.4%];p= .001]. Although appendicular leanmass (ALM)/height2
indexwas lower inbothmenandwomenwithHIV, therewerenodifferences ingripstrength,gait speed,orprobable sarcopeniabyHIVstatus.
Olderage, femalesex, lowerALM/height2 index,slowergaitspeed,andHIVinfectionwereall independentlyassociatedwithlowerfemoralneck
BMD. In conclusion, osteoporosis rather than sarcopenia is the commonmusculoskeletal disease of aging in rural South Africa; older women
with HIV may experience greater bone losses than women without HIV. Findings raise concerns over future fracture risk in Southern Africa,
where HIV clinics should consider routine bone health assessment, particularly in agingwomen. © 2021 The Authors. Journal of Bone
and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
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Life expectancy is increasing more rapidly in sub-SaharanAfrica than in any region globally, suggesting that for those
who survive early-life challenges, a long old age is now a
reality.(1) As populations age, burdens of noncommunicable
disease (NCD) are rising, and multimorbidities, including muscu-
loskeletal multimorbidities such as the co-occurrence of osteo-
porosis and sarcopenia are more common.(2) Yet the natural
history of bone and muscle aging in Southern African popula-
tions is poorly understood, largely because population-based
data are limited. However, recent data suggest vertebral
and hip fracture rates are higher among black South African
populations than have hitherto been appreciated.(3,4)
In Southern Africa, although some risk factors for osteoporosis
and sarcopenia including age and female sex may be similar to
those in non-African settings, other factors may also be impor-
tant, such as high prevalence of physical inactivity and human
immunodeficiency virus (HIV) infection.(5) Traditional risk factors,
such as menopausal-associated bone loss, may behave differ-
ently in the context of HIV infection; higher rates of postmeno-
pausal bone loss have been reported in US women living with
HIV than those without.(6) HIV is thought to be deleterious to
bone through a variety of mechanisms; for example, persistent
inflammation, micronutrient and vitamin deficiencies, and
the effects of anti-retroviral therapy (ART) itself.(7,8) To date
South African studies identifying a negative effect of HIV
infection on bone health have been limited to young adults.(7,9)
Globally, sarcopenia, only recently recognized as an emerging
issue for adults living with HIV,(10,11) is associated with multiple
adverse health outcomes including falls, fractures, disability,
and death.(12) Within the context of South Africa, lower leanmass
has been reported in a small number of perimenopausal women
living with HIV,(13) whereas another small study suggested
muscle strength may also be affected,(14) although others report
no association between HIV and lean mass, muscle strength, or
gait speed.(15) Worldwide, sarcopenia definitions vary with the
most recent consensus from the European Working Group on
Sarcopenia in Older People 2 (EWGSOP2), proposing a structured
diagnostic algorithm to aid clinical utility.(12)
There are 16 million adults aged ≥40 years currently living in
South Africa. Given this age group has an estimated HIV preva-
lence of 17.2%,(16) it is important to establish the impact of HIV
on risk of osteoporosis and sarcopenia. We aimed to determine
the prevalence of osteoporosis and sarcopenia; to understand
the associations between age and bone mineral density (BMD)
in both men and women and establish whether these associa-
tions differ according to HIV infection; and to explore the
relationships between sarcopenia and its components (grip
strength, lean mass, and gait speed) and BMD.
Subjects and Methods
Study population
This cross-sectional study was conducted in the Medical
Research Council/Wits University Rural Public Health and Health
Transitions Research Unit (Agincourt) in Bushbuckridge, a rural
subdistrict of the Mpumalanga province, in northeastern
South Africa.(17) The Agincourt Health and Socio-Demographic
Surveillance System (HDSS) site (90,000 people), established in
1992, includes 31 research villages. Annual updates of vital infor-
mation on residents have facilitated a longitudinal platform
supporting observational and interventional work along the life
course involving, among others, individual and population
health, migration, and urbanization.(17-19) Municipal infrastruc-
ture is limited, with inadequate access to water and electricity,
and unemployment rates are high, leading to high rates of labor
migration. Health provision is managed through a primary
healthcare system consisting of six clinics, two health centers,
and three district hospitals. This study of bone and muscle was
nested within a wider study of multimorbidity set up to study
renal disease.(20)
Potential participants were selected from the residents of the
HDSS who form a community-based open cohort of inhabitants
of 25 neighboring villages. Participants who agreed to take part
were visited at home (November 2017 to November 2018), when
questionnaires were administered, anthropometry measured,
and point of care tests performed to determine HIV status and
blood glucose levels. A total of 2759 adults aged 20–80 years,
using a 1 female: 1 male ratio, were invited to participate, of
whom 2021 (80.1%) consented (phase 1). In phase 2, households
were re-visited to offer half the participants a referral date to
attend the clinic for assessments, including BMD and sarcopenia.
Participants who had acute febrile illness, uncontrolled seizures,
or severely elevated blood pressure, and womenwhowere preg-
nant or breast-feeding were excluded. In total 933 individuals
(46.2%) attended for further assessments, from whom we were
able to ascertain dual-energy X-ray absorptiometry (DXA) and
muscle measures and an HIV status in 665 of 2021 (32.4%). We
supplemented this population by further word-of-mouth recruit-
ment within the same community (phase 3). Of 245 who volun-
teered, 140 (57%) had a DXA and muscle measures performed,
and their HIV status established (Supplemental Fig. S1).
DXA
BMD and body composition were assessed using a Hologic Dis-
covery A DXA scanner (analyzed using version 13.5 software)
(Hologic Inc., Bedford, MA, USA), measuring lumbar spine (LS)
(L1–L4), total hip (TH), femoral neck (FN), and total body less head
(TB-LH) BMD (the head was excluded due to potential artifact
from hair accessory use in women), together with TB-LH fat-free
soft tissue mass (as a proxy for lean mass) and fat mass. Appen-
dicular lean mass (ALM) was calculated as the sum of the fat-free
soft tissue mass in both upper and lower limbs. All DXAs were
performed by one trained radiographer, with coefficients of var-
iation for BMD of 0.94% for TB and 1.08% for TH. BMD Z-scores
for those age <50 years and T-scores for those ≥50 years were
derived using white sex-specific reference data from the
National Health and Nutrition Examination Survey (NHANES)
III,(21) as recommended by the International Society for Clinical
Densitometry (ISCD) for African populations in the absence of
country (or region)-specific reference data.(22)
Assessment of sarcopenia
Upper limb grip strength was measured as the highest of three
right-handed and three left-handed measures of hand dyna-
mometry using a Baseline Digital Smedley Spring Hand Dyna-
mometer (Fabrication Enterprises Inc., White Plains, NY,
USA).(23) Maximal gait speed (meters per second) over 6 m was
measured because it declines more steeply between 20 and
80 years than normal walk speed(24): after a practice walk, they
were asked to “walk as fast as you can” between two lines on
the floor, with the mean of three measurements taken. Because
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there is no consensus on the definition of sarcopenia in African
populations, we followed the most recent recommended
approach proposed by the European Working Group on Sarco-
penia in Older People 2 (EWGSOP2) to define a three-category
variable(12): (i) probable sarcopenia based on low muscle
strength (grip strength <16 kg for women, <27 kg for men);
(ii) confirmed sarcopenia when, in addition, low muscle quantity
was confirmed by a lean mass index (ALM/height2 index
<5.5 kg/m2 for women, <7.0 kg/m2 for men); (iii) severe sarcope-
nia when low physical performance was also evident using gait
speed (gait speed ≤0.8 m/s).(12)
Demographic and clinical variables
We collected data on demographic factors including age, sex,
place of residence, tobacco smoking, alcohol use, and gravidity.
Women were asked if they considered themselves to still be
“of child-bearing potential.” Medical history and treatment for
chronic diseases such as HIV and diabetes mellitus were self-
reported using the World Health Organization (WHO) STEPwise
Approach to NCD Risk Factor Surveillance (STEPS).(25) Socioeco-
nomic status (SES) was derived using methodology validated
within this population (based on housing type and household
assets) and participants were assigned to SES quartiles.(26)
We estimated physical activity using the active transport domain
(eg, walking and cycling) of the Global Physical Activity Ques-
tionnaire.(27,28) We measured height and weight, and calculated
body mass index (BMI) as weight/height2 (kg/m2): underweight
(<18.5 kg/m2), normal weight (18.5–24.99 kg/m2), overweight
(25.0–29.99 kg/m2), and obese (>30.0 kg/m2).
HIV testing
Those who reported being HIV positive had their ART history
recorded. If they had not been tested or reported being HIV
negative, HIV testing and counseling was offered with testing
conducted according to 2015 National Guidelines, which included
onward referral to HIV services for those newly diagnosed and/or
not linked to care.(29) Those with self-reported HIV and those with
a confirmed HIV status were included in analyses.
Ethical considerations
Ethical approval was granted by the University of the Witwaters-
rand Human Research Ethics Committee (#M160938) and the
Mpumalanga Research and Ethics Committee. Written informed
consent, in the participant’s first language (primarily Shangaan)
was obtained from participants.
Statistical analyses
Data were managed in Research Electronic Data Capture (REDCap;
https://projectredcap.org/) and exported to Stata 15 (StataCorp,
College Station, TX, USA) for analyses.(30,31) All quantitative variables
were assessed for normality and outliers. Normally distributed vari-
ables are presented as mean  standard deviation (SD), whereas
non-normally distributed variables are presented as median with
an interquartile range (IQR). Categorical variables are presented as
frequencies and proportions. Comparisons of continuous variables
between men and women, and between those with and without
HIV, were performed using the Student’s t test and the Mann-
Whitney U or Kruskal-Wallis test for normally and non-normally dis-
tributed variables, respectively, whereas the chi-square test was
used to compare categorical variables.
Linear regression was used to determine the association
between age and BMD, stratified by sex, HIV status, and by age
group (<50 years or ≥50 years), then linear regression betas were
used in a piecewise regression model to maximize precision
(generating standard errors for the beta), while taking account
of any non-constant relationship between age and BMD in the
two age strata. Multivariable linear regression was used to deter-
mine the factors independently associated with BMD. An initial
simple model adjusted for age and sex. Then the individual com-
ponents of sarcopenia (grip strength, ALM/height2, gait speed),
plus fat mass (given the high prevalence of obesity in
South Africa) and HIV status were added to determine the inde-
pendent predictors of BMD. Fat mass was used in preference to
body weight to avoid over adjustment of ALM/height2. The cor-
relations between the individual components of sarcopenia
were checked, and variance inflation factors (VIFs) were checked
after fitting the models to avoid colinearity. Logistic regression
was used to determine the association between the presence
of osteoporosis and sarcopenia. To determine whether women
with HIV, age ≥50 years (as a proxy for menopause) had evidence
of altered BMD, compared with womenwithout HIV, we used our
fully adjusted model (age, grip strength, ALM/height2, gait
speed, and fat mass) and tested whether the association
between age (<50 years or ≥50 years) and BMD outcomes dif-
fered by HIV status using the likelihood ratio test.
Results
Characteristics of study participants
The 805 study participants with complete DXA data and an
established HIV status were more often female, overweight/
obese, of higher SES, and were marginally older than those
who were invited but did not have complete data
(Supplemental Table S1). Four individuals who lacked grip
strength and 36 lacking gait speeds were similar to those with
completemusclemeasures (Supplemental TableS2). The547women
and 258 men studied were of similar age (mean  SD, 44.8  14.2
and 44.1  16.1 years, respectively); however, men were more
likely to drink alcohol, smoke tobacco, and have lower SES
than women (Table 1). All participants identified as black
South African. Among women, 34.2% self-reported no longer
being of child-bearing potential. Only 27 (6.1%) women were
nulliparous, whereas 194 (61.8%) had had three or more
children. Seventeen (7.5%) men and 39 (8.2%) women had
diabetes mellitus (self-reported and/or random plasma glucose
≥11.1 mmol/l). No person reported taking oral steroids, nor did
any woman report use of estrogen replacement therapy. Men
spent more time walking and/or cycling than women. Although
menwere taller than women, womenwere heavier with substan-
tially higher BMI; 73.1% of women were classified as overweight
or obese compared to 43% men (Table 1).
In total, 34 (13.2%) men and 129 (23.6%) women were living
with HIV (146 self-reported an established diagnosis and
17 tested positive), of whom 143 (88%) were taking ART. Both
women andmenwith HIV were less likely to be obese than those
without HIV (Table 1).
BMD and the prevalence of osteoporosis in those with and
without HIV
Women had lower measured BMD at all four skeletal sites
compared with men, with lower TB-LH and LS Z-scores, with no
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marked sex differences seen in TH or FN Z-scores (Table 2).
Women with HIV had lower absolute BMD, and substantially
lower BMD Z-scores at all skeletal sites compared with those
without HIV, particularly at the FN (mean Z-score difference
0.47; 95% confidence interval [CI], 0.25–0.69). Similarly, men with
HIV had lower absolute FN BMD and BMD Z-score than those
without HIV (mean Z-score difference 0.49; 95% CI, 0.06–0.92),
with differences at non-hip sites being less pronounced.
Among those age ≥50 years (n = 296) the prevalence of
osteoporosis (T-score ≤ 2.5) in women was 18.4% (95% CI,
13.3–24.5) at the LS, 19.4% (95% CI, 14.2–25.6) at the FN, and
5.0% (95% CI, 2.4–9.0) at the TH, whereas in men prevalence
was 8.4% (95% CI, 3.7–15.9), 4.2% (95% CI, 1.2–10.4), and 3.2%
(95% CI, 0.7–9.0), respectively (Table 2). In women, osteoporosis
was more common at all skeletal sites in those with HIV (37%
[95% CI, 21.5–55.1] of women with HIV age ≥50 years had osteo-
porosis at the FN compared to 15.7% [95% CI, 10.5–22.1] in
women without HIV); in men HIV was not associated with the
presence of osteoporosis, although numbers were small.
Prevalence of sarcopenia in men and women with and
without HIV
Within the study population overall, the three sarcopenia mea-
sures were all positively correlated with one another, although
not strongly: gait speed versus ALM/height2 r = 0.16, ALM/
height2 versus grip strength r = 0.39, and grip strength versus
gait speed r = 0.43. In both men and women, lean mass and
ALM were lower in those living with HIV than without, whereas
grip strength and gait speed were similar. However, only
19 men and five women were classified as having low ALM/
height2. Hence, overall, 11.6% (95% CI, 8.0–16.2) men and 4.4%
(95% CI, 2.8–6.5) women were found to have probable sarcope-
nia, with no individual having confirmed or severe sarcopenia.
Probable sarcopenia was not associated with HIV infection.
Notably, fat mass wasmarkedly lower in those with HIV infection.
Among all men and women aged 50 years and older, osteo-
porosis at the TH was associated with higher odds of probable
sarcopenia (odds ratio [OR] 5.6; 95% CI, 1.54–20.3; p = 0.009);
however, this association was not seen at the other skeletal sites
(Supplemental Table S3).
Age associations with BMD in those with and without HIV
In women, BMDmeasurements at all four skeletal sites were sim-
ilar across the age range 20 to 50 years, both in those with and
without HIV (Fig. 1). In women age ≥50 years, inverse associa-
tions were observed between age and BMD at the TB-LH, TH,
and FN, but not at the LS, with no evidence that these inverse
associations were stronger in those women living with HIV. In
men above and below the age of 50 years there was little evi-
dence of an association between age and BMD at any skeletal
site (Fig. 1).
Factors associated with BMD
In unadjusted analyses, older age, female sex, and HIV infection
were all strongly associated with lower BMD at all four skeletal
sites, and greater ALM/height2, grip strength, and gait speed
were all strongly associated with higher BMD, again at all four
skeletal sites. Greater fat mass was associated with greater LS,
TH, and FN BMD, but lower TB-LH BMD. Physical activity was only
weakly positively associated with TB-LH BMD (Supplemental
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associations between HIV infection and lower BMD were still evi-
dent at all four skeletal sites, whereas the associations between
greater ALM/height2 and grip strength both remained strongly
associated with higher BMD (at all sites), as was fat mass.
However, associations between both gait speed and physical
activity and BMD were attenuated (Supplemental Table S5).
Multivariable models were then used to determine the inde-
pendent associations between the exposures age, sex, HIV
Fig. 1. Unadjusted relationships between age andmeasures of BMD at four skeletal sites in females andmales above and below the age of 50 years, living
with andwithout HIV. Age against BMD is shown on scatter plots. Individuals with HIV are indicated by blue triangles, those without HIV by green circles. In
women, 94 (27.2%) of those age <50 years and 35 (17.4%) of those ≥50 years were living with HIV. In men, 22 (13.5%) of those age <50 years and
12 (12.6%) of those ≥50 years were living with HIV. Piecewise regression lines are shown; β (standard error) represents g/cm2 per year of age. No evidence
was detected for an interaction between age and HIV status on BMDoutcomes in either the younger or oldermen or women in these unadjusted analyses.
BMD = bone mineral density; HIV = human immunodeficiency virus.
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infection, grip strength, ALM/height2, gait speed, and fat mass,
and BMD at each of the four skeletal sites. As expected, older
age and female sex were consistently and independently associ-
ated with lower BMD at all four sites (Table 3). Of the three mea-
sures of sarcopenia, ALM/height2 showed the strongest
independent relationships with FN and TH BMD, and to a lesser
extent TB-LH, with no association with LS BMD. Grip strength
was independently associated with BMD at the TH, LS, and TB-
LH, but much less so at the FN. Gait speed was only weakly asso-
ciated with FN BMD. In thesemultivariable analyses, fat mass was
only associated with LS BMD, whereas HIV infection was only
associated with FN BMD. Overall, the seven variables in our
models explained almost one-half of the variance in TB-LH
BMD, just over one-third at the two hip sites, and only 19% of
the variance in LS BMD (VIF <3).
Modification of the effect of age on BMD by HIV infection
in women
Among the 335 women age <50 years with complete data for all
variables, those with (n = 89) and without (n = 245) HIV had
similar measures of TB-LH BMD (mean difference 0.013
[95% CI, 0.030, 0.0003] g/cm2), whereas in 187 women
age ≥50 years, those with HIV (n = 33) had 0.045 [95% CI,
0.012–0.077] g/cm2 lower TB-LH BMD than those without HIV
(n= 154) (interaction p= 0.027). Consistent but weaker patterns
were seen at the TH, LS, and FN BMD.
Discussion
We studied a rural-dwelling South African population with a high
prevalence of HIV and obesity. Overall osteoporosis was com-
mon in those age ≥50 years and in women; with high reported
ART use, HIV infection was strongly associated with osteoporosis
at all skeletal sites; 37% of older women with HIV had femoral
neck osteoporosis. In both men and women, HIV infection was
associated with an approximately 0.5 SD lower femoral neck
BMD. By contrast, overall, the numbers with probable sarcopenia
were low, with no confirmed or severe sarcopenia identified.
Osteoporosis prevalence has not previously been estimated
using data from a population-based study in Southern Africa.
Table 3. Multivariable Analysis to Determine Risk Factors Independently Associated With BMD for Each of the Four Skeletal Sites
Parameter β coefficient 95% CI p r2
FN BMD (g/cm2) 0.37
Age (decade) 0.035 (0.042, 0.028) <0.001
Sex (female) 0.077 (0.113, 0.040) <0.001
HIV infection 0.024 (0.046, 0.002) 0.031
Grip strength 0.010 (0.001, 0.021) 0.065
ALM/height2 0.047 (0.023, 0.070) <0.001
Gait speed 0.013 (0.001, 0.024) 0.031
Fat mass 0.016 (0.011, 0.043) 0.238
TH BMD (g/cm2) 0.36
Age (decade) 0.024 (0.031, 0.017) <0.001
Sex (female) 0.096 (0.133, 0.060) <0.001
HIV infection 0.015 (0.036, 0.007) 0.192
Grip strength 0.014 (0.003, 0.025) 0.012
ALM/height2 0.045 (0.022, 0.069) <0.001
Gait speed 0.010 (0.002, 0.021) 0.093
Fat mass 0.016 (0.011, 0.042) 0.253
LS BMD (g/cm2) 0.19
Age (decade) 0.025 (0.033–0.016) <0.001
Sex (female) 0.103 (0.146, 0.060) <0.001
HIV infection 0.009 (0.035, 0.017) 0.511
Grip strength 0.016 (0.003, 0.029) 0.015
ALM/height2 0.009 (0.019, 0.036) 0.528
Gait speed 0.003 (0.017, 0.010) 0.646
Fat mass 0.046 (0.014, 0.078) 0.005
TB-LH BMD (g/cm2) 0.48
Age (decade) 0.010 (0.015, 0.006) <0.001
Sex (female) 0.127 (0.151, 0.103) <0.001
HIV infection 0.004 (0.018, 0.010) 0.596
Grip strength 0.012 (0.005, 0.019) 0.001
ALM/height2 0.022 (0.006, 0.037) 0.005
Gait speed 0.005 (0.002, 0.013) 0.161
Fat mass 0.002 (0.016, 0.019) 0.863
β coefficient represents the SD increase in BMD per SD increase in continuous exposures, or decade increase in age, being female versusmale, or having
HIV+ versus HIV. Each β coefficient is adjusted for the other six variables in each model. r2 indicates the proportion of variance in the BMD outcome
explained by the seven variables in the model.
ALM = appendicular lean mass; BMD = bone mineral density; CI = confidence interval; FN = femoral neck; HIV = human immunodeficiency virus;
LS = lumbar spine; TB-LH = total body less head; TH = total hip.
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Two small cross-sectional studies from Cameroon and Nigeria,
both using quantitative ultrasound to estimate bone density,
reported a prevalence of osteoporosis of 17.9% and 18.2%,
respectively, in women age ≥50 years or who were postmeno-
pausal.(32,33) Amore recent cross-sectional study of 254 postmen-
opausal women living in a peri-urban setting in Kenya identified
an osteoporosis prevalence of 26.4%; HIV was not examined.(34)
In contrast, the osteoporosis prevalence in US populations age
≥50 years is well known, affecting 3.9% and 15.8% of non-
Hispanic white men and women, and 1.3% and 7.7% of non-
Hispanic black men and women, respectively.(35) The prevalence
we report suggest osteoporosis is at least as common a problem
in a rural South African population as it is in the US. Yet none of
the womenwe studied reported use of any osteoporosis medica-
tions, including hormone replacement therapy, to ameliorate
postmenopausal bone loss. Parity was high in this rural
South African population. It is unclear whether short-term losses
in bone density during pregnancy and lactation fully recover in
this population, as they are thought to in high-income
settings.(36)
The HIV-associated bone deficits identified with may in part
be explained by the types of ART regimes used. Of those with
HIV, 88% were established on ART. Although we lacked data
on ART type and duration, at the time of this study the recom-
mended first-line regime for adults in South Africa was (and
still is) tenofovir disoproxil fumarate (TDF), lamivudine (3TC),
and efavirenz (EFV), as a fixed dose combination.(29) TDF in
particular is known to cause 1% to 3% greater BMD loss in
the first 2 years of therapy,(37) by affecting renal tubular func-
tion leading to hyperphosphaturia and reduced skeletal
mineralization.(8)
As expected, we saw inverse associations between age and
BMD in women age ≥50 years, although not in the spine, likely
due to degenerative changes artifactually increasing BMD as
measured by DXA. Although we lacked accurate menopausal
status data, we identified an age (above/below 50 years)*HIV
interaction on TB-LH BMD in women, suggesting greater BMD
losses may be experienced by postmenopausal women living
with HIV than in those who are uninfected. This is consistent with
findings from a small longitudinal study of postmenopausal US
Hispanic and African-American women that showed greater
bone loss in women living with HIV.(6) To our knowledge ours
are the first data to suggest this in an African population and
warrant further longitudinal study, given that routine bone
health assessment in perimenopausal women attending HIV
clinics is not currently the standard of care in South Africa.
Our findings suggest either that, unlike osteoporosis, sarcope-
nia is not common in this population, or that use of the European
thresholds, particularly for grip strength, which defines probable
sarcopenia, is nondifferentiating, in which case further work is
needed to identify context-specific sarcopenia definitions. A
recent meta-analysis identified a 30.3% prevalence of low ALM,
and 4.5% prevalence of sarcopenia, based on 2010 EWGSOP
guidelines,(38) in adults living with HIV, although only three of
41 evaluated studies were conducted in Africa; none used the
newer EWGSOP2 definition.(12,39) In the meta-analysis higher
BMI attenuated HIV-associated deficits in lean mass, which may
explain our findings in this obese South African population.
Although the prevalence of osteoporosis was high and sarcope-
nia was uncommon, the three muscle measures of strength, lean
mass, and gait speed were associated with BMD at different
skeletal sites. Our multivariable models showed clear evidence
for independent associations between lean mass index
(ALM/height2) and hip BMDmeasures, between muscle strength
and all BMD measures except FN BMD, and between gait speed
and FN BMD. All three components of sarcopenia were indepen-
dently associated with hip BMD, although ALM/height2 was the
strongest independent predictor, suggesting each individual
muscle measure may be influencing hip strength by indepen-
dent means. Muscle and bone function are tightly linked; inter-
estingly two small randomized trials in Iran and Malawi have
recently reported beneficial effects of muscle training on BMD
in adults living with HIV, potentially suggesting an intervention
that may help, at least in part, ameliorate the negative effects
of HIV on bone health.(40,41) There is currently no consensus
agreement over the definition of sarcopenia in male and female
African populations.(42,43)
The prevalence of overweight and obesity in this rural
community was striking and of public health concern, affecting
73% of women and 43% of men. The most recent national data
from the South African Demographic and Health Survey
(SADHS) in 2016 reported a prevalence of overweight and/or
obesity of 66.1% and 26.1% in non-urban-dwelling women and
men age ≥15 years, respectively.(44) These estimates had
increased from 2003 when SADHS reported a prevalence of
49.6% and 27.8%, respectively.(45) Fat mass, particularly visceral
fat, is thought to exert negative effects on bone quality, and
hence obesity is recognized as an independent risk factor for
fracture, over and above BMD.(46) Hence the combination seen
here, of low BMD and very high rates of obesity, raises serious
concerns for future fragility fracture incidence.
We used NHANES III reference data from a white population in
North America to derive BMD Z-scores and T-scores in this black
South African population,(21) as recommended by the ISCD in the
absence of region-specific reference data.(22) If these reference
data were a good fit for this population, then those without
HIV should have a mean Z-score close to 0 and SD close to
1. However, this was not seen, suggesting NHANES III data are
not an ideal reference population for use in rural South Africa.
This is unsurprising given evidence that North American and
Southern African populations have marked differences in both
bone density and geometry.(47,48) Although studies are few, data
suggest black South African women living in Johannesburg,
have on average, shorter, wider femoral necks, with smaller
neck-shaft angles and greater cortical thickness, compared with
white South African women, which may explain the higher
observed TH and FN Z-scores observed in this study.(48) Unfortu-
nately, our study population had too few men and women aged
20–29.9 years who did not have HIV, to robustly derive a refer-
ence mean and SD to generate Z-scores in the older individuals.
However, the data we present were sampled to be representa-
tive of a rural South African community, and as such, it is now
possible to use these data together with future population
samples, to derive the first BMD reference data for South Africa.
Strengths and limitations
Our study is the largest study to date of osteoporosis and sarco-
penia conducted in community-based adults in Southern
Africa.(7,9) Limitations include the recruitment of fewer males
than females, and hence male-specific CIs were wider and con-
clusions less certain. Although missing data were few, because
17% of the study sample were recruited through word-of-mouth
(albeit from the same source population) rather than by house-
hold sampling, this may limit generalizability. Gait speed was
measured based on fast walking rather than normal walking,
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which explains the relatively high gait speeds measured in this
population, compared with others.(49) We unfortunately lacked
data on ART regimes, HIV infection duration and severity, and
menopausal age. Because we were only able to study those
who were alive and healthy enough to attend the research clinic,
we may have underestimated the bone and muscle deficits in
the population living (and dying) with HIV in this context. Given
the widespread use of hairpieces in the female population in
South Africa, it was important to use total body-less-head
(TB-LH) estimates of body composition variables to avoid
artifacts; however, NHANES normative data needed to calculate
TB-LH Z-scores were only available for those age <70 years.(21)
Conclusions
In rural South Africa, osteoporosis is common, affecting 19.4% of
women and 8.4% of men aged over 50 years. HIV-associated
bone deficits, particularly at the FN, raise concerns regarding
future hip fracture risk.(4) Further research is needed to under-
stand the effect of HIV on menopausal bone losses in women liv-
ing in Southern Africa. Although sarcopenia was uncommon,
consensus on definitions specific to African populations is lack-
ing. Our findings suggest that HIV clinics in South Africa should
consider routine bone health assessment, particularly in older
women; quantification of osteoporotic fracture risk is now possi-
ble with the recent launch of the new South African Fracture Risk
Assessment Tool (FRAX).(50) However, because osteoporosis
medications are still not on the South African Essential Drugs List,
and even among the private sector osteoporosis is still not con-
sidered a Prescribed Medical Benefit (PMB), osteoporosis treat-
ment is likely to be remain limited until health policies
change.(51) Further follow-up of this population is warranted to
determine fracture incidence and the extent to which BMD and
HIV infection explain fracture risk.
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